Dwarfism and early death in mice lacking C-type natriuretic peptide

被引:353
|
作者
Chusho, H
Tamura, N
Ogawa, Y [1 ]
Yasoda, A
Suda, M
Miyazawa, T
Nakamura, K
Nakao, K
Kurihara, T
Komatsu, Y
Itoh, H
Tanaka, K
Saito, Y
Katsuki, M
Nakao, K
机构
[1] Kyoto Univ, Sch Med, Dept Med & Clin Sci, Kyoto 6068507, Japan
[2] Suntory Inst Biomed Res, Shimamoto, Osaka 6180024, Japan
[3] Univ Tokyo, Inst Med Sci, Lab Anim Res Ctr, Tokyo 1080071, Japan
关键词
D O I
10.1073/pnas.071389098
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Longitudinal bone growth is determined by endochondral ossification that occurs as chondrocytes in the cartilaginous growth plate undergo proliferation, hypertrophy, cell death, and osteoblastic replacement. The natriuretic peptide family consists of three structurally related endogenous ligands, atrial, brain, and C-type natriuretic peptides (ANP, BNP, and CNP), and is thought to be involved in a variety of homeostatic processes. To investigate the physiological significance of CNP in vivo, we generated mice with targeted disruption of CNP (Nppc(-/-) mice). The Nppc(-/-) mice show severe dwarfism as a result of impaired endochondral ossification. They are all viable perinatally, but less than half can survive during postnatal development. The skeletal phenotypes are histologically similar to those seen in patients with achondroplasia, the most common genetic form of human dwarfism. Targeted expression of CNP in the growth plate chondrocytes can rescue the skeletal defect of Nppc(-/-) mice and allow their prolonged survival. This study demonstrates that CNP acts locally as a positive regulator of endochondral ossification in vivo and suggests its pathophysiological and therapeutic implication in some forms of skeletal dysplasia.
引用
收藏
页码:4016 / 4021
页数:6
相关论文
共 50 条
  • [41] C-Type Natriuretic Peptide: What, Where and Why?
    Korostyshevskaya I.M.
    Maksimov V.F.
    Rudenko N.S.
    Neuroscience and Behavioral Physiology, 2016, 46 (8) : 888 - 894
  • [42] C-TYPE NATRIURETIC PEPTIDE (CNP) IN RATS AND HUMANS
    KOMATSU, Y
    NAKAO, K
    SUGA, S
    OGAWA, Y
    MUKOYAMA, M
    ARAI, H
    SHIRAKAMI, G
    HOSODA, K
    NAKAGAWA, O
    HAMA, N
    KISHIMOTO, I
    IMURA, H
    ENDOCRINOLOGY, 1991, 129 (02) : 1104 - 1106
  • [43] MECHANISM OF RELATION TO C-TYPE NATRIURETIC PEPTIDE IN VEINS
    BANKS, M
    WEI, CM
    KIM, CH
    BURNETT, JC
    MILLER, VM
    FASEB JOURNAL, 1995, 9 (03): : A317 - A317
  • [44] C-type natriuretic peptide for tissue engineering applications
    Russo, L.
    Shaikh, N.
    Cipolla, L.
    Nicotra, F.
    Quarto, R.
    Giannoni, P.
    JOURNAL OF BIOTECHNOLOGY, 2010, 150 : S203 - S203
  • [45] C-type natriuretic peptide in growth: A new paradigm
    Olney, Robert C.
    GROWTH HORMONE & IGF RESEARCH, 2006, 16 : S6 - S14
  • [46] C-Type Natriuretic Peptide Analog as Therapy for Achondroplasia
    Legeai-Mallet, Laurence
    ADVANCED THERAPIES IN PEDIATRIC ENDOCRINOLOGY AND DIABETOLOGY, 2016, 30 : 98 - 105
  • [47] C-type natriuretic peptide and longitudinal bone growth
    Olney, Robert
    HORMONE RESEARCH, 2008, 70 : 13 - 13
  • [48] C-type natriuretic peptide regulates metabolic homeostasis
    Perez-Ternero, Cristina
    Aubdool, Aisah
    Makwana, Raj
    Sanger, Gareth
    Stimson, Roland
    Chan, Li
    Moyes, Amie
    Hobbs, Adrian
    JOURNAL OF TRANSLATIONAL MEDICINE, 2023, 21 (SUPPL 1)
  • [49] C-type natriuretic peptide system in rabbit oviduct
    Kim, SH
    Lee, KS
    Lee, SJ
    Seul, KH
    Kim, SZ
    Cho, KW
    PEPTIDES, 2001, 22 (07) : 1153 - 1159
  • [50] THE ROLE OF C-TYPE NATRIURETIC PEPTIDE ON BONE METABOLISM
    Kondo, E.
    AGING CLINICAL AND EXPERIMENTAL RESEARCH, 2024, 36 : S239 - S239